<unk>  (INN) is a prodrug of the nonsteroidal anti-inflammatory drug (NSAID)<unk> , designed to reduce the occurrence of side-effects by esterification of the carboxyl group on<unk>  with<unk> .<unk>  was first approved in Japan in 1991, and is available in Japan and Indonesia, under the trade names Infree and Dialon, respectively.
Indometacin farnesil
Methylergometrine
Ergometrine
Nandrolone cyclohexylpropionate
Drostanolone propionate
Xylometazoline
Diethylstilbestrol dilaurate
Ethinylestradiol sulfonate